12:00 AM
 | 
Nov 05, 2012
 |  BC Week In Review  |  Company News  |  Deals

Ipsen, Novartis deal

Ipsen said in its 3Q12 earnings that in April it terminated a January 2009 deal with Novartis to co-promote the pharma's Exforge...

Read the full 98 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >